356 related articles for article (PubMed ID: 11938063)
1. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
Perret JL; Moussavou-Kombila JB; Delaporte E; Pemba LF; Boguikouma JB; Matton T; Larouze B
Gastroenterol Clin Biol; 2002 Feb; 26(2):131-5. PubMed ID: 11938063
[TBL] [Abstract][Full Text] [Related]
2. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
3. [Case-control study of hepatitis C HBs Ag and antivirus antibodies in chronic hepatopathies].
Maiga MY; Dembele M; Maiga I; Sanago B; Sangare D; Traoré HA
Sante; 2002; 12(4):389-92. PubMed ID: 12626293
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis C virus and chronic hepatopathies in Dakar: case-control study].
Mbaye PS; Renaudineau Y; Diallo A; Haudrechy D; Sane M; Michel G; Raphenon G; Klotz F
Med Trop (Mars); 2000; 60(1):47-52. PubMed ID: 10989787
[TBL] [Abstract][Full Text] [Related]
5. [Etiology of hepatocellular carcinomas in Madagascar: results of a study in Antananarivo from October 1995 to October 1996].
Zeller HG; Rakotonirina J; Morel B; Pécarrère JL; Lapprand M
Arch Inst Pasteur Madagascar; 1996; 63(1-2):62-6. PubMed ID: 12463021
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen.
Al-Moslih MI; Al-Huraibi MA
East Mediterr Health J; 2001; 7(4-5):771-8. PubMed ID: 15332778
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between chronic liver diseases and hepatitis C in Burundi adults].
Aubry P; Larouze B; Muhirwa G; Henzel D; Ndabaneze E; Nsabimana JM
Med Trop (Mars); 1995; 55(3):235-7. PubMed ID: 8559018
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
Ka MM; Ndiaye MF; Herve P; Legueno B; Diop BM; Dangou JM; Niang A; Woto-Gaye G; Mendes V; Diop TM; Ndiaye PD; Bao O
Dakar Med; 1996; Spec No():59-62. PubMed ID: 14520992
[No Abstract] [Full Text] [Related]
11. [HCV and HBV seropositivity in university students of the State of Nuevo Leòn, Mexico].
Flores-Castañeda MS; García-Méndez BL; Tijerina-Menchaca R
Rev Gastroenterol Mex; 1996; 61(4):327-31. PubMed ID: 9072784
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus is a more likely cause of chronic liver disease in the Japanese population than hepatitis B virus.
Hayashi J; Hirata M; Nakashima K; Noguchi A; Kashiwagi S; Matsui M; Ishibashi H; Maeda Y
Fukuoka Igaku Zasshi; 1991 Dec; 82(12):648-54. PubMed ID: 1783356
[TBL] [Abstract][Full Text] [Related]
13. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T
Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790
[TBL] [Abstract][Full Text] [Related]
15. [Markers of the hepatitis B virus and chronic alcoholism. Prevalence and risk factors].
Renard P; Hillon P; Bedenne L; Fourot M; Milan C; Faivre J; Klepping C
Ann Gastroenterol Hepatol (Paris); 1991; 27(1):7-12. PubMed ID: 1851406
[TBL] [Abstract][Full Text] [Related]
16. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of hepatitis B and C virus, HTLV-1 and HIV in type B lymphoproliferative syndromes in Gabon].
Perret JL; Moussavou-Kombila JB; Delaporte E; Minko-Mi-Etoua D; Pemba LF; Boguikouma JB; Nzenze JR; Deparis X; Larouzé B
Bull Soc Pathol Exot; 2003 Nov; 96(4):275-8. PubMed ID: 14717040
[TBL] [Abstract][Full Text] [Related]
18. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.
Ayoola EA; Gadour MO
J Gastroenterol Hepatol; 2004 Jun; 19(6):665-9. PubMed ID: 15151622
[TBL] [Abstract][Full Text] [Related]
20. [Study of antigen HBs and antivirus antibodies of hepatitis C during hepatopathies in Mali].
Dembele M; Maïga I; Minta D; Konate A; Diarra M; Sangare D; Traore HA; Maïga MY; Tounkara A; Payan C; Lunel E; Carbonnelle B; Cales P
Bull Soc Pathol Exot; 2004 Aug; 97(3):161-4. PubMed ID: 15462194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
